Saturday 17 October 2026 Export CSTL’s income statement to Excel — free account

Castle Biosciences, Inc.

Castle Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $344.2 million, up 3.66% from fiscal 2024. In the quarter to June 2026, revenue grew 20.1%, EPS fell 143.8%, free cash flow fell 43.3% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years.

31.96 1.84 −5.44%

Follow CSTL

Alert me

Market cap: $1.0B
P/E: 0.0×
Fwd P/E: −15.2×
Dividend yield: —
F-score: 3/9
Altman Z: 6.70
Beneish M: −3.49
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	3	3	3	3	+8 more TTM periods Free account
ROE Full definition →	(4.20%)	(2.85%)	(5.21%)	(2.69%)
ROA Full definition →	(3.51%)	(2.45%)	(4.35%)	(2.27%)
ROIC Full definition →	(9.40%)	(9.90%)	(14.72%)	(11.50%)
Return on Tangible Assets Full definition →	(4.99%)	(3.37%)	(6.20%)	(3.16%)
Average Days of Receivables Full definition →	49.39	45.38	46.00	52.57
Free Cash Flow per Share Full definition →	(0.01)	0.15	0.98	0.87
Free Cash Flow Full definition →	(0.45)	4.56	28.37	25.42
Capital Expenditures Full definition →	(43.09)	(43.69)	(35.98)	(36.36)
Other line items
Cash ROIC Full definition →	(0.06%)	0.62%	3.63%	3.32%
Accounts Receivable Turnover Full definition →	7.10	6.89	7.28	6.89
Accounts Payable Turnover Full definition →	7.11	6.39	5.55	7.24
Inventory Turnover Full definition →	8.58	8.69	7.73	9.05
Average Days of Payables Full definition →	43.43	73.01	96.15	64.69
Days of Inventory on Hand Full definition →	47.53	50.79	52.69	45.83
Tax Rate Full definition →	0.01	(0.27)	(0.18)	(0.35)
Research and Development Expense of Revenue Full definition →	15.52%	15.79%	15.06%	14.59%
Selling, General and Administrative Expense of Revenue Full definition →	68.20%	69.31%	66.62%	64.79%
Share Based Compensation of Revenue Full definition →	12.56%	13.09%	13.33%	13.37%
Interest Coverage Full definition →	(85.62)	(163.99)	(497.79)	(226.84)
Operating CF/Net income Full definition →	(2.20)	(3.76)	(2.66)	(5.05)
Depreciation/Fixed assets Full definition →	0.13	0.12	0.38	0.44
Capex/Depreciation Full definition →	(3.28)	(3.74)	(0.98)	(0.97)
Revenue per Share Full definition →	11.75	11.37	11.88	11.82
Operating CF per Share Full definition →	1.40	1.61	2.22	2.13
Capex per Share Full definition →	(1.42)	(1.46)	(1.24)	(1.25)
Capex to Sales Full definition →	0.12	0.13	0.10	0.11

Fold the line items

Columns are period end dates

Stockrow Weekly